17:36:40 EST Wed 20 Feb 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:VNDA - VANDA PHARMACE INC - http://www.vandapharma.com17:36:40 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VNDA - Q0.119.50 · 20.950.320.36+0.221.1937.719,2337,68920.16  21.00  20.0333.44  13.87517:17:3715:5215 min RT 2¢

Recent Trades - Last 10 of 7689
Time ETExPriceChangeVolume
17:17:37Q20.400.261
17:01:52Q20.360.22767
16:10:33Q20.360.2226
16:08:25Q20.35870.21874,654
16:08:25Q20.35870.21878,746
16:07:51Q20.360.22381
16:07:47Q20.360.221,413
16:07:45Q20.360.221,374
16:07:44Q20.360.22548
16:07:43Q20.360.22123
 

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2019-02-20 15:52U:VNDANews ReleaseLifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.
2019-02-20 09:52U:VNDANews ReleaseEQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Vanda Pharmaceuticals Inc.; Investors are Encouraged to Contact the Firm – VNDA
2019-02-20 07:40U:VNDANews ReleaseNew Research: Key Drivers of Growth for Arconic, Vanda Pharmaceuticals, Avaya, Sempra Energy, Forward Industries, and Alamo Group — Factors of Influence, Major Initiatives and Sustained Production
2019-02-19 11:00U:VNDANews ReleaseGlancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-02-14 15:00U:VNDANews ReleaseONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-14 11:00U:VNDANews ReleaseGlancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-02-13 17:10U:VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-02-13 16:01U:VNDANews ReleaseVanda Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results
2019-02-13 15:16U:VNDANews ReleaseINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-13 14:37U:VNDANews ReleaseVanda Pharmaceuticals Inc. to Host Earnings Call
2019-02-13 13:00U:VNDANews ReleaseVANDA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals Inc. To Contact The Firm
2019-02-12 16:22U:VNDANews ReleaseINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-12 10:41U:VNDANews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc. (VNDA)
2019-02-12 08:32U:VNDANews ReleaseWolf Popper LLP Announces Investigation on Behalf of Investors in Vanda Pharmaceuticals Inc.
2019-02-11 19:00U:VNDANews ReleaseINVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Vanda Pharmaceuticals Inc.